1. Factual Date: 115/09/11 2. Company Name: HanchorBio Inc. (Chinese Translation: Hanchor Bio-Technology Co., Ltd., Cayman Islands) 3. Relationship with Company (Please specify本公司or Subsidiary):本公司 4. Cross-shareholding Ratio: Not applicable 5. Reason for Occurrence: Announcement of full subscription of restricted employee shares and capital increase effective date. 6. Response Measures: None 7. Other Matters to be Disclosed (If the subject of the event or resolution is a publicly issued company or above, this major information also qualifies as a matter under Article 7, Paragraph 9 of the Enforcement Rules of the Securities and Exchange Act that significantly affects shareholders' rights or securities prices): (1) The company's extraordinary general meeting on August 6, 115, approved the issuance of restricted employee shares, totaling 1,501,036 ordinary shares, which became effective upon filing with the Financial Supervisory Commission on August 21, 115, under reference No. Jin-Guan-Zheng-Fa-11503532511. (2) The board of directors on August 26, 115, resolved to issue restricted employee shares in tranches, totaling 841,867 ordinary shares, with the following issue prices: 393,044 shares at TWD 33.2 per share; 17,826 shares at TWD 50; 419,597 shares at TWD 65; and 11,400 shares at TWD 80, amounting to a total of TWD 42,126,166, which has been fully subscribed. (3) The capital increase effective date for the restricted employee shares is September 11, 115.
FACT BOX
- Source: PR Times
- Category: Funding